Tackling TKI resistance in AML: A commentary on “Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.” by Yamatani et al.

Bibliographic Details
Main Authors:	Özden Hatırnaz Ng, Ahmet Emre Eşkazan
Format:	Article
Language:	English
Published:	Elsevier 2022-05-01
Series:	Translational Oncology
Subjects:	Acute myeloid leukemia AML FLT3 FLT3-ITD/D835 BCL2A1 Resistance
Online Access:	http://www.sciencedirect.com/science/article/pii/S1936523322000560

Internet